What would happen if a total stranger with a poor command of English asked the payroll manager of an American corporation to send him the Internal Revenue Service Form W-2’s for the company’s entire staff?
Answer: Some payroll managers would obligingly... Read more »
BioMarin Pharmaceuticals has won the first FDA approval for a treatment for Batten disease, a rare group of disorders that rob children of vision, cognitive abilities, and motor skills, and usually prove deadly before adulthood.
The San Rafael, CA-based biotech’s cerliponase... Read more »
San Antonio — Academic research centers are perennially seeking new ways to get more work commercialized, from offices that are tasked with spotting marketable science to workshops meant to help scientists learn to think like entrepreneurs.
But the problem may be... Read more »
Richardson, TX—The University of Texas at Dallas today formally kicks off its Blackstone LaunchPad program, one of three cross-disciplinary entrepreneurship centers opening at universities across the state.
The program, funded by a $1 million donation from the charitable arm of... Read more »
Scott Gottlieb’s nomination to the top post of the FDA is on its way to the full U.S. Senate.
The Senate Health, Education, Labor & Pensions Committee voted 14-9 on Thursday to approve Gottlieb’s nomination to become FDA commissioner. All of... Read more »
[Updated 4/27/17 5:29 pm. See below.] A year ago, Exact Sciences’s stock was in a slump, languishing below $10 per share. But since then, its stock price has climbed back to more than $20 per share.
That rally continued... Read more »
Two of the most noteworthy drugs to win FDA approval over the past year, eteplirsen (Exondys 51) and nusinersen (Spinraza), have something important in common: Patient groups have played a critical role in both of their stories.
Eteplirsen, Sarepta Therapeutics’ (NASDAQ:... Read more »
Paul Allen has pledged $30 million to help house homeless families in Seattle, as the city grapples with an ongoing crisis and debates how to pay for it.
With an additional $5 million in capital from city coffers, the funding from... Read more »
Earlier this month, the Michigan State University-backed Conquer accelerator program announced the five startups that will spend the summer pushing their products and technologies to market.
Starting in June, Conquer participants will begin the 10-week incubation program. What makes Conquer different... Read more »
Four months after its drug nusinersen (Spinraza) became the first ever approved to treat the rare genetic disease spinal muscular atrophy, Biogen (NASDAQ: BIIB) released study results Tuesday that could help more patients gain access to the expensive drug.
The... Read more »
[Corrected 4/27/17, 11:57 p.m. See Below.] Arsanis, a Waltham, MA-based biotech co-founded by scientist and entrepreneur Tillman Gerngross to develop treatments for bacterial and viral infections, has raised a $45.5 million investment led by the Bill & Melinda Gates Foundation... Read more »
[Updated 4/26/17, 2:58 pm. See below.] This week in Boston tech, we’re tracking appeals by Uber and Lyft drivers who failed state background checks; a deal between a local wearable device startup and the National Football League Players Association;... Read more »
Jon Zanoff is ready for a new nickname.
Dubbed “The Mayor of Fintech,” Zanoff, the newly appointed managing director of the Barclays Techstars accelerator in New York, has certainly been entrenched in the financial technology industry long enough to deserve the... Read more »